JPM
JPMorgan Chase & Co.
JPM's fundamentals are strong, but it looks expensive: trading at 14x earnings, above its usual 12x. Analysts expect earnings growth.
UMAC
Unusual Machines, Inc.
There isn't enough reported data to score UMAC yet.
JPM Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
JPM's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like JPM.
UMAC Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| N/A | |
| N/A |
UMAC's revenue is currently strong, but its profitability is under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like UMAC.
JPM PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.7x | $231 | -33% |
| Fair | 12x | $287 | -16% |
| Current | 14x | $343 | — |
| Forward | 14x | $343 | — |
| Expensive | 15x | $361 | +5.2% |
Historical ranges are pointers, not guarantees.
JPM's PE is in its expensive range at 14.4x. If earnings grow as analysts expect, today's price would be 13.7x next year's earnings.
UMAC PE Valuation
UMAC has no meaningful PE right now: it lost money over the past year.
JPM Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for JPM, with profitability improving.
UMAC Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect UMAC's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
JPM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $24.99 | +4.8% |
| Q3 2026 | $23.85 | +18% |
| Q2 2026 | $23.35 | +20% |
| Q1 2026 | $20.89 | +2.5% |
| Q4 2025 | $20.02 | +1.4% |
| Q3 2025 | $20.20 | +12% |
| Q2 2025 | $19.50 | +8.7% |
| Q1 2025 | $20.38 | +23% |
| Q4 2024 | $19.75 | +22% |
JPM has the edge over UMAC on earnings quality, reporting a profit while its opponent remains loss making.
UMAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.71 | +$2.97 |
| Q2 2026 | -$0.16 | +$3.87 |
| Q1 2026 | -$0.32 | +$3.55 |
| Q4 2025 | -$0.74 | +$3.10 |
| Q3 2025 | -$3.68 | -$3.20 |
| Q2 2025 | -$4.03 | -$3.81 |
| Q1 2025 | -$3.87 | -$3.76 |
| Q4 2024 | -$3.84 | -$3.84 |
UMAC is still losing money, but far less than before: $0.71 per share over the past year, against $4.03 at its worst in mid-2025.
JPM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $50.2B | +8.1% |
| Q2 2026 | $57.3B | +28% |
| Q1 2026 | $49.8B | +10% |
| Q4 2025 | $45.8B | +7.1% |
| Q3 2025 | $46.4B | +8.8% |
| Q2 2025 | $44.9B | -11% |
| Q1 2025 | $45.3B | +8.1% |
| Q4 2024 | $42.8B | +11% |
JPM's revenue has grown year over year for five quarters in a row: $50.2B last quarter, up 8.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 40% | -0.2 points |
| Q2 2026 | 48% | +7.3 points |
| Q1 2026 | 41% | +0.5 points |
| Q4 2025 | 37% | -3.2 points |
| Q3 2025 | 40% | +0.6 points |
| Q2 2025 | 41% | -6 points |
| Q1 2025 | 41% | -0.6 points |
| Q4 2024 | 41% | +11 points |
JPM has the edge over UMAC on profitability, with a higher operating margin.
UMAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $13.9M | +551% |
| Q2 2026 | $16.7M | +687% |
| Q1 2026 | $8.1M | +296% |
| Q4 2025 | $4.9M | +144% |
| Q3 2025 | $2.1M | +39% |
| Q2 2025 | $2.1M | +51% |
| Q1 2025 | $2M | +230% |
UMAC has the edge over JPM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -60% | +172 points |
| Q2 2026 | -47% | +292 points |
| Q1 2026 | -90% | +70 points |
| Q4 2025 | -199% | +444 points |
| Q3 2025 | -232% | -137 points |
| Q2 2025 | -339% | -227 points |
| Q1 2025 | -160% | +16 points |
| Q4 2024 | -642% | N/A |
UMAC's operating margin was −60% last quarter, up 172 points from the same quarter a year ago.
JPM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $33.2B | +$78.4B |
| Q2 2026 | -$25.3B | -186% |
| Q1 2026 | -$211.8B | +$40.1B |
| Q4 2025 | $119.7B | -19% |
| Q3 2025 | -$45.2B | +$28.9B |
| Q2 2025 | $29.5B | -23% |
| Q1 2025 | -$251.8B | -$97.7B |
| Q4 2024 | $147.8B | +145% |
JPM has the edge over UMAC on cash flow, with more consistent year-over-year improvement.
UMAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$40.6M | -$31.8M |
| Q1 2026 | -$18.1M | -$16.9M |
| Q4 2025 | -$10.3M | -$9M |
| Q1 2025 | -$1.2M | +$2K |
| Q4 2024 | -$1.3M | -$1.3M |
| Q2 2024 | -$986.2K | -$505.8K |
| Q1 2024 | -$1.2M | -$653.2K |
| Q4 2023 | -$17.3K | +$489K |
UMAC's free cash flow was −$90M over the past year, against −$12M the year before. Free cash flow isn't a meaningful measure for financial services companies like UMAC.
JPM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -11.2M shares |
| 1 year | -3.1% | -84.6M shares |
| 3 years | -8.5% | -249M shares |
| 5 years | -11% | -322M shares |
| Available history | -17% | -547M shares |
JPM has the edge over UMAC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.1B |
| Q2 2026 | $6.8B |
| Q1 2026 | $8.3B |
| Q4 2025 | $8.3B |
| Q3 2025 | $8.3B |
| Q2 2025 | $7.5B |
| Q1 2025 | $7.5B |
| Q4 2024 | $4.3B |
JPM spent $24.5B buying back its own shares over the past year, down 11% from the year before.
UMAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.8% | +1.4M shares |
| 1 year | +130% | +28.2M shares |
| 3 years | +473% | +41.3M shares |
UMAC has 50M diluted shares, up 130% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
JPM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.5x | Very low |
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | 0.5x | Very low |
| Q3 2025 | 0.6x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.4x | Very low |
JPM's net debt is less than a year of its operating earnings (EBITDA). Net leverage isn't a meaningful measure for financial services companies like JPM.
UMAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q4 2023 | -12.8x | Net Cash |
UMAC has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like UMAC.
JPM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.8 | Neutral |
| Stochastic | 31.5 | Neutral |
JPM's weekly RSI is 55 (neutral) and its Stochastic is 31 (neutral).
UMAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 38.2 | Neutral |
| Stochastic | 5.8 | Oversold |
UMAC's weekly RSI is 38 (neutral) and its Stochastic is 6 (oversold).
JPM PE vs Financial Services Sector
| Metric | JPM | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 13x | 10% above |
| PE % | 76 | 63 | 13 pts above |
JPM is trading at 14x earnings, a 10% premium to the Financial Services sector's median of 13x.
UMAC PE vs Financial Services Sector
UMAC has no meaningful PE right now: it lost money over the past year.
JPM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $336.8 | 1.8% above |
| 20 week MA | $345.3 | 0.7% below |
| 50 week MA | $323.2 | 6.1% above |
| 100 week MA | $298.9 | 15% above |
| 200 week MA | $236.6 | 45% above |
JPM has stronger trend alignment. JPM is above 4 of 5 weekly averages versus UMAC above 0 of 4.
UMAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $17.5 | 32% below |
| 20 week MA | $21.0 | 44% below |
| 50 week MA | $18.0 | 34% below |
| 100 week MA | $13.9 | 15% below |
UMAC is in a downtrend: it's below all four of its weekly moving averages, and 15% below its 100-week average.
JPM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $139.1 | $124.5 | -11% |
| 2021 | $124.5 | $157.3 | +26% |
| 2022 | $157.3 | $131.3 | -17% |
| 2023 | $131.3 | $170.1 | +30% |
| 2024 | $170.1 | $241.2 | +42% |
| 2025 | $241.2 | $327.9 | +36% |
| 2026 YTD | $327.9 | $342.8 | +4.5% |
JPM has the edge over UMAC on returns for 2026, with the stronger performance.
UMAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $2.99 | $17.0 | +468% |
| 2025 | $17.0 | $12.2 | -28% |
| 2026 YTD | $12.2 | $11.8 | -3.1% |
UMAC has finished lower in one of the last two years. It's down 3.1% so far in 2026.